Use of estrogen-progestins in secondary prevention
Modena, M.G.; Origliani, G.; Rossi, R.
Italian Heart Journal. Supplement Official Journal of the Italian Federation of Cardiology 1(3): 435-436
2000
ISSN/ISBN: 1129-4728 PMID: 10815281 Document Number: 516279
Document emailed within 1 workday
Related Documents
Gaspard, U.; Lambotte, R. 1991: Metabolic impact of current estrogen-progestins and cardiovascular consequences Bulletin et Memoires de l'Academie Royale de Medecine de Belgique 146(8-10): 334-342; Discussion: 342-345Santen, R.J.; Pinkerton, J.; McCartney, C.; Petroni, G.R. 2001: Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy Journal of Clinical Endocrinology and Metabolism 86(1): 16-23
Sitruk-Ware, R.; Nath, A. 2013: Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills Best Practice and Research. Clinical Endocrinology and Metabolism 27(1): 13-24
Luttge, W.G.; Jasper, T.W.; Gray, H.E.; Sheets, C.S. 1977: Estrogen-induced sexual receptivity and localization of 3H-estradiol in brains of female mice: effects of 5 alpha-reduced androgens, progestins and cyproterone acetate Pharmacology Biochemistry and Behavior 6(5): 521-528
Kamernitskiĭ, A.V.; Levina, I.S.; Kulikova, L.E.; Milovanov, A.P.; Khalanskiĭ, A.S.; Altukhova, V.I.; Smirnov, A.N.; Pokrovskaia, E.V.; Shevchenko, V.P. 2002: Morphological changes in the rat uterine tissues exposed to pregna-D'-pentaran derivatives of progestins and anti-progestins Bioorganicheskaia Khimiia 28(3): 261-268
Nightingale, A.; Marshall, A. 1998: Secondary prevention in acute myocardial infarction. Long term insulin treatment is important in secondary prevention in diabetic patients Bmj 317(7166): 1153
Anonymous 2000: Progestins, Progesterone Receptor Modulators, and Progesterone Antagonists. Progesterone, progestins and antiprogestins in the next millennium, Jerusalem, Israel, 31 August-3 September, 1999 Steroids 65(10/11): 543-850
Medrela-Kuder, E. 2012: Junior secondary and secondary school students' knowledge level about atherosclerosis risk factors and prevention Roczniki Panstwowego Zakladu Higieny 63(2): 219-223
Rockel, P.; Hoffmann, B.; Kyrein, H.J. 1978: Relationships between the size of ovarian follicles, the binding capacity of uterine estrogen receptors and estrogen concentrations in the follicular fluid and urine of calves under estrogen therapy Berliner und Munchener Tierarztliche Wochenschrift 91(24): 476-479
Mscichowski, O; Muzzey, A; Cope-Barnes, D; Hunt, A; Ott, M 2017: Primary Versus Secondary Prevention in Evidence-Based Pregnancy Prevention Programs for System-Involved Adolescents Journal of Adolescent Health 60(2): S97-S98
Mscichowski, O; Muzzey, A; Cope-Barnes, D; Hunt, A; Ott, M 2017: Primary Versus Secondary Prevention in Evidence-Based Pregnancy Prevention Programs for System-Involved Adolescents Journal of Adolescent Health 60(2): S97-S98
Blankenstein, M.A.; Mulder, E.; Broerse, J.J.; Van Der Molen, H.J. 1980: Mammary gland estrogen receptors and plasma prolactin during estrogen enhanced rat mammary tumor development strain difference in the response to estrogen Radiation and Environmental Biophysics 17(4): 359
Novák, J. 1988: The program for primary prevention and secondary prevention of ischemic coronary disease and research at the Laboratory of Human Energy Resources of the University of Wyoming in Laramie Casopis Lekaru Ceskych 127(37-38): 1190-1192
Tilsner, V. 1994: Estrogen antagonists and thrombosis prevention Deutsche Medizinische Wochenschrift 119(34-35): 1182
Lutsep, H.L. 2007: New developments in secondary stroke prevention: impact of the European/Australasian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) on clinical management Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association 16(6): 263-267
Algra, A. 1994: SPIRIT: new life spirit for anticoagulant treatment in the secondary prevention of brain infarcts? A new study. Stroke Prevention in Reversible Ischaemia Trial Nederlands Tijdschrift Voor Geneeskunde 138(20): 1037-1039
Rachev, E.; Katsarova, M.; Trepechov, S. 1989: Estrogen-gestagen prevention and treatment of uterine hemorrhages in the premenopause Akusherstvo i Ginekologiia 28(3): 78-81
Lindsay, R.; Hart, D.M.; Clark, D.M. 1984: The minimum effective dose of estrogen for prevention of postmenopausal bone loss Obstetrics and Gynecology 63(6): 759-763
Gao, X.; Xue, Y.; Zheng, M. 1999: Effect of physiological dosage of estrogen on the prevention of bone loss in rats induced by ovariectomy Wei Sheng Yan Jiu 28(4): 227-229
Kahán, Z. 1996: Current questions about estrogen receptor determination and hormone dependence (does estrogen receptor positivity equal estrogen dependence?) Orvosi Hetilap 137(42): 2305-2308